Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2. (19th October 2022)
- Record Type:
- Journal Article
- Title:
- Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2. (19th October 2022)
- Main Title:
- Antibody and T-Cell Subsets Analysis Unveils an Immune Profile Heterogeneity Mediating Long-term Responses in Individuals Vaccinated Against SARS-CoV-2
- Authors:
- Agallou, Maria
Koutsoni, Olga S
Michail, Maria
Zisimopoulou, Paraskevi
Tsitsilonis, Ourania E
Karagouni, Evdokia - Abstract:
- Abstract: Background: Based on the fact that coronavirus disease 2019 (COVID-19) is still spreading despite worldwide vaccine administration, there is an imperative need to understand the underlying mechanisms of vaccine-induced interindividual immune response variations. Methods: We compared humoral and cellular immune responses in 127 individuals vaccinated with either BNT162b2, mRNA-1273, or ChAdOx1-nCoV-19 vaccine. Results: Both mRNA vaccines induced faster and stronger humoral responses as assessed by high spike- and RBD-specific antibody titers and neutralizing efficacy in comparison to ChAdOx1-nCoV-19 vaccine. At 7 months postvaccination, a decreasing trend in humoral responses was observed, irrespective of the vaccine administered. Correlation analysis between anti-S1 IgG and interferon-γ (IFN-γ) production unveiled a heterogeneous immune profile among BNT162b2-vaccinated individuals. Specifically, vaccination in the high-responder group induced sizable populations of polyfunctional memory CD4 + helper T cells (TH 1), follicular helper T cells (TFH ), and T cells with features of stemness (TSCM ), along with high neutralizing antibody production that persisted up to 7 months. In contrast, low responders were characterized by significantly lower antibody titers and memory T cells and a considerably lower capacity for interleukin-2 and IFN-γ production. Conclusions: We identified that long-term humoral responses correlate with the individual's ability to produceAbstract: Background: Based on the fact that coronavirus disease 2019 (COVID-19) is still spreading despite worldwide vaccine administration, there is an imperative need to understand the underlying mechanisms of vaccine-induced interindividual immune response variations. Methods: We compared humoral and cellular immune responses in 127 individuals vaccinated with either BNT162b2, mRNA-1273, or ChAdOx1-nCoV-19 vaccine. Results: Both mRNA vaccines induced faster and stronger humoral responses as assessed by high spike- and RBD-specific antibody titers and neutralizing efficacy in comparison to ChAdOx1-nCoV-19 vaccine. At 7 months postvaccination, a decreasing trend in humoral responses was observed, irrespective of the vaccine administered. Correlation analysis between anti-S1 IgG and interferon-γ (IFN-γ) production unveiled a heterogeneous immune profile among BNT162b2-vaccinated individuals. Specifically, vaccination in the high-responder group induced sizable populations of polyfunctional memory CD4 + helper T cells (TH 1), follicular helper T cells (TFH ), and T cells with features of stemness (TSCM ), along with high neutralizing antibody production that persisted up to 7 months. In contrast, low responders were characterized by significantly lower antibody titers and memory T cells and a considerably lower capacity for interleukin-2 and IFN-γ production. Conclusions: We identified that long-term humoral responses correlate with the individual's ability to produce antigen-specific persistent memory T-cell populations. Abstract : A longitudinal study conducted in 2021 revealed that the long-term humoral responses against SARS-CoV-2 detected among BNT162b2-vaccinated individuals correlated with individual's ability to produce persistent antigen-specific TFH and CD4 + T-cell memory populations. … (more)
- Is Part Of:
- Journal of infectious diseases. Volume 227:Number 3(2023)
- Journal:
- Journal of infectious diseases
- Issue:
- Volume 227:Number 3(2023)
- Issue Display:
- Volume 227, Issue 3 (2023)
- Year:
- 2023
- Volume:
- 227
- Issue:
- 3
- Issue Sort Value:
- 2023-0227-0003-0000
- Page Start:
- 353
- Page End:
- 363
- Publication Date:
- 2022-10-19
- Subjects:
- COVID-19 -- antibodies -- central memory T cells -- cytokines -- high and low responders -- immune response -- stem cell memory T cells -- vaccines
Communicable diseases -- Periodicals
Diseases -- Causes and theories of causation -- Periodicals
Medicine -- Periodicals
Communicable Diseases -- Periodicals
Electronic journals
616.9 - Journal URLs:
- http://jid.oxfordjournals.org/content/by/year ↗
http://www.journals.uchicago.edu/JID/journal/ ↗
http://www.jstor.org/journals/00221899.html ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/infdis/jiac421 ↗
- Languages:
- English
- ISSNs:
- 0022-1899
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25703.xml